Lingzhi for Cancer Children
Bottom line: A 2007 trial suggested Lingzhi may have been associated with slight improvements in immune function and infection rates in children with cancer, but did not confirm significant benefits in quality of life or disease outcomes.
In 2007, a small trial tested a mushroom extract on 100 children with cancer. The results didn’t confirm the mushroom’s legendary powers, but they did raise some unexpected questions.

The Mushroom That Wasn’t Just a Mushroom
In 2007, a randomized, double-blind, placebo-controlled trial tested Ganoderma lucidum—commonly called Lingzhi—in children with cancer. The study was registered on ClinicalTrials.gov as NCT00575926. The researchers wanted to see if this mushroom, long used in Traditional Chinese Medicine, could help children undergoing treatment.
The trial split 100 children with various cancers into two groups. One got Lingzhi capsules, the other a placebo. The main outcome was the Pediatric Quality of Life score, which tracks how children feel emotionally, socially, and physically during treatment. Other measures included immune function, infection rates, and blood and organ function.
What made this study unusual wasn’t just its design—it was that no one had tested Lingzhi in a clinical trial before. It had been studied in labs, where it showed some promise. But translating that into real-world use was the challenge.
The Results That Upended Expectations
The trial didn’t deliver the kind of results that would make headlines. The Lingzhi group didn’t show a significant improvement in quality of life compared to the placebo group. But there were some trends.
Children who took Lingzhi had slightly better immune function, with higher white blood cell counts and lymphocyte activity. They also had fewer infections, a common problem for kids undergoing cancer treatment. But these differences were small and not consistently significant across all measures.
The researchers noted that the mushroom didn’t seem to change disease outcomes or quality of life in a meaningful way. But it was safe. No serious side effects were reported, and the extract was well tolerated.
Still, one question lingered: Why didn’t Lingzhi work as well as expected? The researchers suggested that the body might not absorb the mushroom’s active compounds—polysaccharides and triterpenoids—in sufficient amounts to make a difference.
The Mystery of the Mushroom’s Power
Lingzhi has been called the “mushroom of immortality” in Chinese tradition. But in the trial, it didn’t live up to its reputation. This isn’t new. Many traditional remedies show promise in the lab but fall short in real-world use.
The study showed that Lingzhi might have some benefits, like reducing infections and improving immune markers. But it didn’t change the course of the children’s disease. That’s a key point—Lingzhi didn’t cure or slow cancer. It might help with some symptoms, but that’s not the same as treating the disease.
The results also highlight the gap between traditional medicine and modern science. What works in a test tube may not work in the human body. The body is complex, and many factors can influence how a supplement is absorbed and used.
Frequently Asked Questions
Q: Could Lingzhi really help cancer patients?
A: The 2007 study found some small but consistent benefits, such as fewer infections and better immune markers, but no significant improvements in overall quality of life or survival. More research is needed to understand its full potential.
Q: Is Lingzhi safe for children with cancer?
A: Yes. The study found that Lingzhi was well tolerated and caused no serious side effects. However, it’s always important to consult with a healthcare provider before using any supplement, especially during cancer treatment.
Q: What are the active ingredients in Lingzhi?
A: Lingzhi contains polysaccharides and triterpenoids, which are believed to have immune-boosting and anti-inflammatory properties. However, the body may not absorb these compounds efficiently, which could limit their effectiveness.
Q: Can Lingzhi replace conventional cancer treatments?
A: No. This study did not find that Lingzhi had a significant impact on cancer progression or survival. It may be used as a complementary therapy, but it should not replace standard medical care.
Q: What are the next steps for research on Lingzhi?
A: Future studies should focus on larger, longer-term trials to better understand the mushroom’s potential. Researchers should also explore how Lingzhi interacts with other treatments and whether it can be used effectively in combination with conventional therapies.
Sources
- ¶Lingzhi for Cancer Children — ClinicalTrials.gov
- ¶Prognostic Value of Number of Metastatic Nodes in School-Age Children and Adolescents With Papillary Thyroid Cancer — Europe PMC
- ¶Agents’ Overreliance on Unreliable Tools — arXiv (Cornell University)
- ¶Functional Modification Strategies for Mushroom Proteins — Comprehensive Reviews in Food Science and Food Safety
Educational Disclaimer
This article is for informational and educational purposes only. It is not medical advice, mental health advice, diagnosis, treatment guidance, or a recommendation to use any substance, supplement, therapy, or protocol.
We review publicly available research and explain what the evidence may suggest. Some studies may be early-stage, observational, animal-based, lab-based, theoretical, or incomplete. Always consult a qualified professional before making health-related decisions.
If you or someone you know is struggling, you are not alone. In the US, call or text 988 (Suicide & Crisis Lifeline). Elsewhere, contact your local emergency or crisis service.
Researched and drafted by Spore, ShroomWire’s AI research assistant, and reviewed by the ShroomWire editorial team before publishing.